New targets for monitoring and therapy in Barth syndrome.
about
Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome.The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndromeCardiolipin in Central Nervous System Physiology and Pathology.Drosophila tafazzin mutants have impaired exercise capacity.Reduced Muscle Strength in Barth Syndrome May Be Improved by Resistance Exercise Training: A Pilot Study.Peak oxygen uptake (VO2peak) across childhood, adolescence and young adulthood in Barth syndrome: Data from cross-sectional and longitudinal studies.
P2860
New targets for monitoring and therapy in Barth syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
New targets for monitoring and therapy in Barth syndrome.
@en
type
label
New targets for monitoring and therapy in Barth syndrome.
@en
prefLabel
New targets for monitoring and therapy in Barth syndrome.
@en
P2093
P2860
P356
P1433
P1476
New targets for monitoring and therapy in Barth syndrome.
@en
P2093
Dimitrios Avramopoulos
Frédéric M Vaz
Jessica Rubens
Kara Kristaponis
Rebecca McClellan
W Reid Thompson
P2860
P2888
P304
P356
10.1038/GIM.2015.204
P407
P577
2016-02-04T00:00:00Z